###begin article-title 0
XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development
###end article-title 0
###begin p 1
###xml 542 547 542 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 552 557 552 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/cre</sup>
###xml 584 588 584 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 784 788 784 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1159 1163 1159 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 590 595 <span type="species:ncbi:10090">mouse</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 849 854 <span type="species:ncbi:10090">mouse</span>
###xml 1164 1168 <span type="species:ncbi:10090">mice</span>
The unfolded protein response (UPR) is a stress response pathway that is driven by the increased load of unfolded proteins in the endoplasmic reticulum of highly secretory cells such as plasma cells (PCs). X box binding protein 1 (XBP1) is a transcription factor that mediates one branch of the UPR and is crucial for the development of antibody-secreting PCs. PCs represent only one class of terminally differentiated B cells, however, and little is known about the role for XBP1 in the other class: memory B cells. We have developed an XBP1fl/fl CD19+/cre conditional knockout (XBP1CD19) mouse to build upon our current understanding of the function of XBP1 in PC differentiation as well as to explore the role of XBP1 in memory cell development. Using this model, we show that XBP1CD19 mice are protected from disease in an autoantibody-mediated mouse lupus model. We also identify a novel developmental stage at which B cells express the traditional PC marker CD138 (syndecan-1) but have yet to undergo XBP1-dependent functional and morphological differentiation into antibody-secreting cells. Finally, we show that memory B cells develop normally in XBP1CD19 mice, demonstrating that XBP1-mediated functions occur independently of any memory cell lineage commitment.
###end p 1
###begin p 2
###xml 302 319 302 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Todd et al., 2008</xref>
###xml 637 657 637 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Yoshida et al., 2001</xref>
###xml 659 678 659 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Calfon et al., 2002</xref>
###xml 680 696 680 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Lee et al., 2002</xref>
###xml 955 975 955 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Yoshida et al., 2001</xref>
###xml 977 996 977 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Calfon et al., 2002</xref>
###xml 998 1014 998 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Lee et al., 2002</xref>
###xml 1130 1150 1130 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Shaffer et al., 2004</xref>
###xml 1152 1168 1152 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Lee et al., 2005</xref>
Proper protein folding is essential for normal immunoglobulin synthesis and secretion in antibody-secreting plasma cells (PCs). The mammalian unfolded protein response (UPR) is a signaling pathway that responds to ER stress that is induced by the accumulation of unfolded proteins within the ER lumen (Todd et al., 2008). Inositol-requiring transmembrane kinase/endonuclease 1 (IRE1) is an ER-localized transmembrane protein that senses unfolded proteins and serves to activate X-box binding protein 1 (XBP1), a member of the CREB/ATF basic leucine zipper family of transcription factors and a crucial mediator of one branch of the UPR (Yoshida et al., 2001; Calfon et al., 2002; Lee et al., 2002). IRE1 possesses endoribonuclease activity that excises a 26-nt sequence from XBP1 messenger RNA (mRNA). This event, termed XBP1 splicing, shifts the reading frame to excise a premature stop codon, resulting in a full-length functional XBP1 protein product (Yoshida et al., 2001; Calfon et al., 2002; Lee et al., 2002). XBP1 then translocates to the nucleus where it induces target genes involved in protein synthesis and secretion (Shaffer et al., 2004; Lee et al., 2005).
###end p 2
###begin p 3
###xml 143 161 143 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Kaser et al., 2008</xref>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 313 333 313 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Reimold et al., 2001</xref>
###xml 572 593 572 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Iwakoshi et al., 2003</xref>
###xml 595 615 595 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Shaffer et al., 2004</xref>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
XBP1 activation is crucial to the normal function and survival of highly secretory cells such as exocrine gland acinar cells and Paneth cells (Kaser et al., 2008). Using XBP1/RAG2-/- lymphoid chimeric mice, we have shown previously that XBP1 expression is required for normal PC development and function as well (Reimold et al., 2001). Chimeric mice demonstrated markedly reduced serum Ig levels and impaired Ig response to immunization. This defect was the result of a failure of cells to up-regulate UPR-related XBP1 target genes during terminal B cell differentiation (Iwakoshi et al., 2003; Shaffer et al., 2004). The requirement of XBP1 for PC differentiation raises the possibility that disruption of XBP1 activity may represent a potential therapeutic target for the treatment of autoimmune diseases, such as systemic lupus erythematosus (SLE), in which autoantibodies may be directly pathogenic.
###end p 3
###begin p 4
###xml 334 379 334 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">McHeyzer-Williams and McHeyzer-Williams, 2005</xref>
###xml 515 541 515 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Sanderson and B&#248;rset, 2002</xref>
###xml 646 691 646 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">McHeyzer-Williams and McHeyzer-Williams, 2005</xref>
###xml 753 773 753 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Neubert et al., 2008</xref>
Little is known about the role of XBP1 in the development and function of another important B cell population: memory B cells. These B cells have been exposed to antigen, undergo a germinal center (GC) reaction, and function to differentiate rapidly into antibody-secreting B cells after reexposure to cognate antigen (for review see McHeyzer-Williams and McHeyzer-Williams, 2005). They do not express CD138 (syndecan-1), a cell surface glycoprotein which has traditionally been used a marker for Ig-secreting PCs (Sanderson and Borset, 2002). Memory B cells also function to replete the pool of long-lived antibody-secreting PCs (for review see McHeyzer-Williams and McHeyzer-Williams, 2005), which may represent a persistent source of autoantibodies (Neubert et al., 2008).
###end p 4
###begin p 5
###xml 32 36 32 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox</sup>
###xml 65 82 65 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Hetz et al., 2008</xref>
###xml 295 312 295 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Zhou et al., 1991</xref>
###xml 314 338 314 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Hardy and Hayakawa, 2001</xref>
###xml 367 371 367 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox</sup>
###xml 496 516 496 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Rickert et al., 1997</xref>
###xml 568 577 568 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 582 587 582 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cre/+</sup>
###xml 593 597 593 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 663 666 663 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 691 711 691 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Reimold et al., 2001</xref>
###xml 750 754 750 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 871 874 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 880 881 880 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 912 916 912 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 943 952 943 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 957 960 957 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 966 969 966 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1009 1013 1009 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 376 381 <span type="species:ncbi:10090">mouse</span>
###xml 387 392 <span type="species:ncbi:10090">mouse</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 780 785 <span type="species:ncbi:10090">mouse</span>
###xml 917 921 <span type="species:ncbi:10090">mice</span>
###xml 1014 1018 <span type="species:ncbi:10090">mice</span>
The recent development of a XBP1flox conditional KO (cKO) mouse (Hetz et al., 2008) has prompted us to explore further the function of XBP1 in terminal B cell development. CD19 expression is limited to B cells and occurs in pro-B cells and throughout the remaining stages of B cell development (Zhou et al., 1991; Hardy and Hayakawa, 2001). We therefore bred the XBP1flox cKO mouse to a mouse expressing cre recombinase under the control of CD19 promoter to delete XBP1 selectively from B cells (Rickert et al., 1997). In the current series of experiments, we use XBP1flox/flox CD19cre/+ (XBP1CD19) cKO mice first to confirm the functional PC defects in XBP1/RAG2-/- lymphoid chimeric mice (Reimold et al., 2001). In addition, we now report that XBP1CD19 mice were protected from mouse lupus. We also show, unexpectedly, that the number of cells with the traditional B220int CD138+ PC phenotype is normal in XBP1CD19 mice as compared with XBP1flox/flox CD19+/+ (XBP1+/+) controls. Finally, we report that XBP1CD19 mice have normal populations of memory B cells, demonstrating that this alternative differentiation pathway for B cells is not dependent on the XBP1 branch of the UPR.
###end p 5
###begin title 6
RESULTS AND DISCUSSION
###end title 6
###begin title 7
###xml 32 36 32 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Initial characterization of XBP1CD19 cKO mice
###end title 7
###begin p 8
###xml 67 71 67 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 403 407 403 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 416 419 416 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 551 555 551 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
To determine the efficiency of XBP1 deletion in the B cells in XBP1CD19 mice, splenocytes from these mice were isolated and separated into B220+ and B220- populations using magnetic beads coupled to an anti-B220 mAb. Southern blotting demonstrated efficient and specific deletion of XBP1 in the B220+ (B cell) fraction (). There were no differences in cell surface expression of IgM and IgD between XBP1CD19 and XBP1+/+ splenocytes (Fig. S1 B). In accord with the known function of XBP1 in PC development, basal Ig levels were markedly reduced in XBP1CD19 mice (Fig. S1 C). Furthermore, these mice exhibited impaired Ig responses to the T cell-dependent antigen nitrophenol (NP)-KLH upon primary or secondary stimulation (, respectively). A similar defect was observed in mice immunized with the T cell-independent antigen NP-ficoll (Fig. S2 C).
###end p 8
###begin p 9
###xml 379 396 375 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Todd et al., 2008</xref>
###xml 409 410 405 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 441 445 437 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 454 457 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 786 789 778 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 881 885 873 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 912 916 904 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1076 1080 1067 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1089 1092 1080 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 1093 1097 <span type="species:ncbi:10090">mice</span>
XBP1 up-regulates the expression of UPR-related target genes that function collectively in protein synthesis and secretion. XBP1 targets include the ER-associated degradation protein EDEM, ER-localized chaperones like ER-localized Dnajb9 (ERdj4), the ER translocon component Sec61alpha, and proteins, such as protein disulfide isomerase (PDI), that aid disulfide bond formation (Todd et al., 2008). Using B220+ splenocytes isolated from XBP1CD19 and XBP1+/+ mice, we next measured the expression of XBP1 target genes in these B cells after culture for 0-3 d in the presence or absence of 10 microg/ml LPS (). As expected, quantitative PCR analysis demonstrated that, by day 3 of culture, there were significant increases in the expression of the aforementioned XBP1 target genes in XBP1+/+ B cells. These same target genes were up-regulated to a lesser degree or not at all in XBP1CD19 B cells. In addition, XBP1CD19 B cells did not demonstrate an appropriate up-regulation of muS, which normally allows for newly synthesized IgM to be secreted. Importantly, B cells from XBP1CD19 and XBP1+/+ mice showed no difference in their modest increase in expression of Ig heavy chain binding protein (BiP), another UPR related gene which is not directly downstream of XBP1.
###end p 9
###begin p 10
###xml 126 130 126 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 139 142 139 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 369 373 369 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 650 654 650 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 774 777 774 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 802 822 802 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Reimold et al., 2001</xref>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
XBP1 deletion did not affect B cell proliferation or viability in response to LPS treatment. Both were comparable between XBP1CD19 and XBP1+/+ B cells as measured by exclusion of 7-amino-actinomycin D (7-AAD) and annexin V (Fig. S3 B) or by exclusion of trypan blue (Fig. S3 C). In contrast, XBP1 deletion led to markedly reduced secretion of IgM by LPS-stimulated XBP1CD19 B cells (Fig. S3 D). Collectively, these data demonstrate that XBP1 deletion leads to defects in the UPR that impair normal synthesis and secretion of immunoglobulin without affecting B cell viability or proliferative properties. Importantly, these initial experiments in XBP1CD19 mice recapitulated the known roles of XBP1 in PC development and function, as has been shown previously using XBP1/RAG2-/- lymphoid chimeric mice (Reimold et al., 2001).
###end p 10
###begin p 11
###xml 151 170 151 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Calame et al., 2003</xref>
###xml 548 567 548 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Calame et al., 2003</xref>
###xml 630 650 630 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Shaffer et al., 2004</xref>
###xml 652 670 652 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Klein et al., 2006</xref>
###xml 862 882 862 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Shaffer et al., 2004</xref>
###xml 964 968 964 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1196 1200 1196 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1227 1230 1227 1230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1620 1635 1620 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Hu et al., 2009</xref>
We next investigated the impact of XBP1 deficiency on the broader network of transcriptional regulators that direct PC differentiation (for review see Calame et al., 2003). The transcription factors Bcl-6 (B cell lymphoma 6) and paired box gene 5 (Pax5) repress B lymphocyte-induced maturation protein 1 (Blimp1) and IFN regulatory factor 4 (IRF4), respectively, and promote B cell proliferation and the GC reaction. On the contrary, Blimp1 and IRF4 normally arrest cell cycle progression and the GC reaction to promote and sustain PC development (Calame et al., 2003). Furthermore, Blimp1 and IRF4 permit the expression of XBP1 (Shaffer et al., 2004; Klein et al., 2006). For Blimp1, this regulatory event is accomplished by Blimp1-mediated repression of Pax5, which derepresses XBP1 to ensure an appropriate UPR in anticipation of Ig production and secretion (Shaffer et al., 2004). Despite the failure to differentiate into Ig-secreting PCs, LPS-stimulated XBP1CD19 B cells displayed a typical PC signature of these transcription factors: down-regulation of Pax5 and up-regulation of Blimp1 and IRF4 mRNAs. Interestingly, Blimp1 and IRF4 were substantially overexpressed in LPS-stimulated XBP1CD19 B cells compared with XBP1+/+ controls (Fig. S3 A). These data suggest that XBP1 deletion did not alter the genetic program of PC development. Furthermore, failure to up-regulate Ig secretion in the absence of XBP1 appears to promote the PC developmental program, supporting the hypothesis that a mechanism of feedback inhibition exists whereby XBP1 down-regulates Blimp1 and IRF4 expression in LPS-stimulated B cells (Hu et al., 2009).
###end p 11
###begin title 12
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Mice with XBP1-deficient B cells are protected from mouse lupus
###end title 12
###begin p 13
###xml 209 236 209 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Putterman and Diamond, 1998</xref>
###xml 506 507 506 507 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 540 558 540 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Kowal et al., 2004</xref>
###xml 754 776 754 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">DeGiorgio et al., 2001</xref>
###xml 778 796 778 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Kowal et al., 2006</xref>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 651 657 <span type="species:ncbi:9606">humans</span>
###xml 677 682 <span type="species:ncbi:10090">mouse</span>
###xml 718 723 <span type="species:ncbi:9606">human</span>
BALB/c mice develop anti-double-stranded DNA (dsDNA) autoantibodies and immune complex deposits in glomeruli when immunized with a DNA mimotope, the decapeptide DWEYSVWLSN on a polylysine backbone (MAP-DWEYS; Putterman and Diamond, 1998). Furthermore, when treated with LPS to disrupt the blood brain barrier, MAP-DWEYS-immunized mice develop lesions in the hippocampus of the brain, a process which is attributable to excitatory cell death induced by stimulatory autoantibodies bound to neuronal N-methyl-d-aspartic acid (NMDA) receptors (Kowal et al., 2004). Anti-NMDA receptor autoantibodies have also been identified in the cerebrospinal fluid of humans with SLE, and this mouse system has been used as a model of human central nervous system lupus (DeGiorgio et al., 2001; Kowal et al., 2006).
###end p 13
###begin p 14
###xml 66 70 66 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 175 179 175 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 387 390 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 440 444 440 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 451 466 451 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, A and B</xref>
###xml 604 612 604 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 778 782 778 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 783 788 <span type="species:ncbi:10090">mouse</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
###xml 915 920 <span type="species:ncbi:10090">mouse</span>
We next sought to use this mouse model of SLE to test whether XBP1CD19 mice were capable of developing autoantibodies and associated pathological findings of mouse lupus. XBP1CD19 and litter-matched XBP1+/+ mice were immunized with MAP-DWEYS three times over a 1-mo period, as described in Materials and methods. Serum anti-peptide and anti-dsDNA antibodies were readily detected in XBP1+/+ control mice but were only weakly present in XBP1CD19 mice (Fig. 1, A and B). These same mice were then treated with 3 mg/kg LPS and killed 4-7 d later for immunohistochemistry (IHC) analysis of kidney and brain (Fig. 1 C). IHC revealed abundant IgG in glomeruli of five out of five control mice and in the hippocampus of two out of five controls, but none was present in any of the XBP1CD19 mouse tissues. Thus, mice with B cells deficient in XBP1 were protected from autoantibody production and disease expression in this mouse model of SLE.
###end p 14
###begin p 15
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 23 27 23 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 0 171 0 163 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Female XBP1<sup>+/+</sup> and XBP1<sup>CD19</sup> mice were immunized i.p. with 100 &#181;g MAP-DWEYS in CFA followed by booster immunizations with 100 &#181;g MAP-DWEYS in IFA on days 14 and 28.</bold>
###xml 372 375 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 400 404 390 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 434 437 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 446 450 436 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 656 659 646 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 792 796 782 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 82 85 <span type="species:ncbi:31658">CFA</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">mice</span>
Female XBP1+/+ and XBP1CD19 mice were immunized i.p. with 100 microg MAP-DWEYS in CFA followed by booster immunizations with 100 microg MAP-DWEYS in IFA on days 14 and 28. (A and B) On day 35, serum was tested for anti-DWEYS (peptide; A) and anti-dsDNA (B) antibodies by ELISA of four serum dilutions. In both panels, each circle represents the mean +/- SEM value for XBP1+/+ (closed circles) or XBP1CD19 (open circles) mice. (C) XBP1+/+ and XBP1CD19 mice from A and B were treated i.p. with 3 mg/kg LPS on days 52 and +54. Shown are representative images of IgG-specific IHC of kidney (top) and hippocampus (bottom) of mice 4-7 d after LPS treatment. XBP1+/+ mice demonstrated anti-IgG binding to neurons in the CA1 region of the hippocampus. There was no anti-IgG binding in any of the XBP1CD19 animals. Bars: (kidney) 200 microm; (hippocampus) 100 microm. All panels represent results from a single experiment with five mice per group. A second independent experiment reproduced these findings (not depicted).
###end p 15
###begin p 16
###xml 268 288 268 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Neubert et al., 2008</xref>
###xml 584 602 584 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Obeng et al., 2006</xref>
###xml 682 703 682 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Zinszner et al., 1998</xref>
###xml 705 727 705 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brewer and Diehl, 2000</xref>
###xml 844 860 844 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Lee et al., 2003</xref>
###xml 862 880 862 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Obeng et al., 2006</xref>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 236 241 <span type="species:ncbi:9606">human</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 418 423 <span type="species:ncbi:10090">mouse</span>
This observation is reminiscent of a recent compelling study in which two lupus-prone mouse strains (NZB/W F1 and MRL/lpr) were treated with bortezomib, a selective inhibitor of the 26S proteosome which is used therapeutically to treat human myeloma, a PC malignancy (Neubert et al., 2008). When treated with bortezomib, these lupus-prone mice lacked autoantibodies, were devoid of mature PCs, and were protected from mouse lupus. Proteasome inhibitors suppress ER-associated degradation pathways such that misfolded proteins accumulate in cells, cause ER stress, and induce the UPR (Obeng et al., 2006). Chronic ER stress, however, causes cell cycle arrest and cellular apoptosis (Zinszner et al., 1998; Brewer and Diehl, 2000). Proteasome inhibitors like bortezomib are toxic to myeloma cells, in part through targeting the activity of IRE1 (Lee et al., 2003; Obeng et al., 2006). These findings raise the intriguing notion that inhibition of XBP1 or the UPR in general may represent a potential therapeutic target in the treatment of autoantibody-mediated diseases like SLE.
###end p 16
###begin title 17
The developmental defect in XBP1-deficient PCs occurs after CD138 expression
###end title 17
###begin p 18
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 240 264 240 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Hardy and Hayakawa, 2001</xref>
###xml 386 389 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 395 396 395 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 404 430 404 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Sanderson and B&#248;rset, 2002</xref>
###xml 463 467 463 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 476 479 476 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 593 597 593 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 674 678 674 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 687 690 687 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 726 729 726 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 735 736 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 750 758 750 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 768 772 768 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 865 873 865 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 914 917 914 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 923 924 923 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 940 944 940 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1092 1100 1092 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 1103 1120 1103 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Hetz et al., 2008</xref>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
XBP1CD19 mice allow us to explore further the developmental stage at which PC differentiation arrests. Complicating this analysis, however, is the observation that PCs down-regulate many B cell surface markers such as B220, CD19, and CD20 (Hardy and Hayakawa, 2001). Traditionally, cell surface expression of CD138 by B cells has been viewed as a marker for antibody-secreting PCs (B220int CD138+ cells; Sanderson and Borset, 2002). Accordingly, we immunized XBP1CD19 and XBP1+/+ mice with NP-KLH to measure the distribution of B220 and CD138 staining over time. Surprisingly, even though XBP1CD19 mice had markedly impaired Ig responses to immunization (Fig. S2), both XBP1CD19 and XBP1+/+ mice had comparable numbers of B220int CD138+ splenocytes (Fig. 2 A). In XBP1CD19 mice, these cells lacked the expanded ER and perinuclear cuff of Golgi found in normal PCs (Fig. 2 B). This difference was quantifiable; B220int CD138+ cells from XBP1CD19 mice demonstrated less intensive staining by brefeldin A boron-dipyrromethane (BODIPY), which selectively binds to secretory ER and Golgi content (Fig. 2 C) (Hetz et al., 2008).
###end p 18
###begin p 19
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 16 20 16 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 0 94 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XBP1<sup>+/+</sup> and XBP1<sup>CD19</sup> mice were immunized i.p. with a single 100-&#181;g dose of NP-KLH in alum.</bold>
###xml 222 225 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 234 238 230 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 316 319 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 325 326 319 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 355 358 349 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 364 365 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 747 750 741 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 756 757 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 782 783 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 789 790 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 940 943 932 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 949 950 941 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 979 980 971 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 986 987 978 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 1043 1047 <span type="species:ncbi:10090">mice</span>
XBP1+/+ and XBP1CD19 mice were immunized i.p. with a single 100-microg dose of NP-KLH in alum. (A) Representative flow cytometry of cell surface CD138 (y axis) and B220 (x axis) expression in splenocytes isolated from XBP1+/+ and XBP1CD19 mice at days 0, 5, and 14 after immunization. Mean percentage +/- SEM of B220int CD138+ cells is indicated. (B) B220int CD138+ cells were isolated by FACS from a subset of splenocytes at day 5 after immunization. Cytospin preparations of cells were stained with modified Wright-Giemsa stain. (C) Splenocytes were isolated from mice on day 5 after immunization and incubated with Brefeldin A BODIPY, which selectively stains ER and Golgi organelles. Shown are representative flow cytometry histograms for B220int CD138+ cells (solid line), B220+ CD138- cells (long dashed line), and unstained cells (short dashed line). Brefeldin A-BODIPY mean fluorescence intensity (MFI) +/- SEM is indicated for B220int CD138+ cells (no difference in B220+ CD138- cells). All experiments were performed with individual mice in at least three independent experiments.
###end p 19
###begin p 20
###xml 52 56 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 113 116 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 139 140 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 262 265 262 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 271 272 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 408 409 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 436 442 436 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 625 629 624 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 669 672 668 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 678 679 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 695 699 694 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 708 711 707 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 949 953 947 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1346 1391 1344 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">McHeyzer-Williams and McHeyzer-Williams, 2005</xref>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
5 d after NP-KLH immunization, splenocytes from XBP1CD19 and XBP1+/+ mice were isolated and FACS sorted into B220int CD138+ and B220+ CD138- cell populations, from which RNA was purified for quantitative PCR analysis. In accord with what is known about PCs, B220int CD138+ cells from XBP1+/+ mice expressed much greater levels of the XBP1 target genes ERdj4, EDEM, PDI, and Sec61 as compared with B220+ CD138- cells from the same mice (Fig. 3). There were also increased levels of BiP, muS, Blimp1, and IRF4 and reduced levels of Pax5. These differences were also observed, but to a much lesser degree, in the two sorted XBP1CD19 B cell populations. When comparing B220int CD138+ cells from XBP1CD19 and XBP1+/+ mice, XBP1 target genes and muS were reduced in expression in cKO cells, and levels of BiP and Pax5 were similar. Unlike what was observed in LPS-stimulated B cells, however, levels of Blimp1 and IRF4 were not elevated in cells from XBP1CD19 mice. This supports the hypothesis that there are multiple pathways of B cell differentiation depending on the specific exogenous stimulus. Indeed, in vitro LPS-stimulated B cells behave differently than in vivo immunogen-stimulated B cells, and this is likely caused, in part, by the absence of T helper cell activity as well as by the different activation pathways involved (for review see McHeyzer-Williams and McHeyzer-Williams, 2005).
###end p 20
###begin p 21
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 16 20 16 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 0 94 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XBP1<sup>+/+</sup> and XBP1<sup>CD19</sup> mice were immunized i.p. with a single 100-&#181;g dose of NP-KLH in alum.</bold>
###xml 177 178 173 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 184 185 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 201 204 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 210 211 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 444 447 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 467 471 461 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
XBP1+/+ and XBP1CD19 mice were immunized i.p. with a single 100-microg dose of NP-KLH in alum. At day 5 after immunization, splenocytes were isolated and sorted by FACS for B220+ CD138- (B220) and B220int CD138+ (CD138) populations. Panels show relative expression of indicated mRNA versus actin as measured by RT-PCR of cDNA prepared from indicated cell populations. In all panels, each bar represents the mean +/- SEM value of individual XBP1+/+ (open bar) and XBP1CD19 (solid bar) mice in three independent experiments.
###end p 21
###begin p 22
###xml 37 41 37 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 493 517 493 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Sanderson and Yang, 2008</xref>
###xml 714 745 714 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Liebersbach and Sanderson, 1994</xref>
###xml 783 803 783 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Stanley et al., 1995</xref>
###xml 877 896 877 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Ridley et al., 1993</xref>
###xml 1067 1091 1067 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Sanderson and Yang, 2008</xref>
Collectively, our data show that XBP1CD19 B cells can survive and differentiate to the developmental stage at which they express CD138, at which point they developmentally arrest. This occurs before achieving normal PC morphology and functional activity because of a failure to up-regulate XBP1-dependent UPR target genes. CD138 is a member of the syndecan family of heparin sulfate proteoglycans and is comprised of a transmembrane core protein covalently bonded to heparin sulfate moieties (Sanderson and Yang, 2008). CD138 also exists as part of the bone marrow stroma and in a soluble form that may be shed from cell membranes. Cell surface-bound CD138 impairs invasion of myeloma cells through collagen gels (Liebersbach and Sanderson, 1994), facilitates cell-cell aggregation (Stanley et al., 1995), and promotes myeloma adhesion to collagen in the extracellular matrix (Ridley et al., 1993). These functions have been hypothesized to explain the organ selectivity of myeloma cells, and CD138 is being investigated as a potential therapeutic target in myeloma (Sanderson and Yang, 2008).
###end p 22
###begin p 23
###xml 360 382 360 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Sanderson et al., 1989</xref>
###xml 449 467 449 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Lalor et al., 1992</xref>
###xml 479 480 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 526 553 526 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Angelin-Duclos et al., 2000</xref>
###xml 601 602 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 793 820 793 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Shapiro-Shelef et al., 2003</xref>
###xml 822 842 822 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Kallies et al., 2007</xref>
###xml 1035 1055 1035 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Kallies et al., 2007</xref>
###xml 1109 1127 1109 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Klein et al., 2006</xref>
The role of CD138 in normal PCs, however, is less well defined, although it may have similar bone marrow homing functions in PCs as in myeloma cells. CD138 is expressed on the cell surface of PCs and bone marrow-resident B cell precursors. It is not present on the surface of mature naive B cells in the bone marrow, circulation, or secondary lymphoid organs (Sanderson et al., 1989). CD138 expression has been closely correlated with Ig secretion (Lalor et al., 1992), and CD138+ plasmablasts have been previously described (Angelin-Duclos et al., 2000), but the existence of a non-Ig-secreting CD138+ cell population has not been formally demonstrated until now. The converse has been seen, however, in that Blimp1-deficient B cells do not express CD138 but can secrete small amounts of Ig (Shapiro-Shelef et al., 2003; Kallies et al., 2007). However, this represents an earlier (initial) developmental stage of PC differentiation in that these cells are unable to attain the large secretory capabilities or phenotype of mature PCs (Kallies et al., 2007). IRF4-deficient B cells also fail to express CD138 (Klein et al., 2006).
###end p 23
###begin p 24
###xml 415 418 415 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 443 463 443 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Reimold et al., 2001</xref>
###xml 497 500 497 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 740 761 740 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Iwakoshi et al., 2007</xref>
###xml 880 881 880 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 924 928 924 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
Our findings therefore indicate that in developing PCs, Blimp1 and IRF4 expression precedes CD138 expression, which is then followed by XBP1-directed UPR transcriptional events and large-scale immunoglobulin secretion. This differs from our previously published results in which CD138 was not detected on the surface of XBP1-deficient B cells 9 d after immunization with 2,4-dinitrophenyl (DNP)-albumin in XBP1/RAG2-/- lymphoid chimeric mice (Reimold et al., 2001). One limitation of the XBP1/RAG2-/- lymphoid chimeric model, however, is that it cannot ascribe this difference solely to an intrinsic deficiency of XBP1 in B cells. With the recent discovery that XBP1 is important for the normal development and function of dendritic cells (Iwakoshi et al., 2007), one could conjecture that XBP1 function in non-B cell populations might in part explain the reduced numbers of CD138+ cells in the chimeric mice. Thus, the XBP1CD19 cKO system provides some refinement in our understanding of the relationship between XBP1 and CD138 expression.
###end p 24
###begin title 25
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Post-GC memory cells and preplasma memory cells are intact in mice with B cells that lack XBP1
###end title 25
###begin p 26
###xml 104 149 104 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">McHeyzer-Williams and McHeyzer-Williams, 2005</xref>
###xml 506 507 506 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 513 514 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 549 550 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 556 557 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 563 564 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 581 626 581 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">McHeyzer-Williams and McHeyzer-Williams, 2005</xref>
Memory B cells make up the second major population of terminally differentiated B cells (for review see McHeyzer-Williams and McHeyzer-Williams, 2005). They are long-lived antigen-specific cells that reside mainly in peripheral tissues, including in the lung, gut, and peripheral lymphoid organs. When reexposed to cognate antigen, memory B cells proliferate, and a subset differentiates into antibody-secreting PCs. Memory B cell subpopulations can be distinguished phenotypically as post-GC B cells (B220+ CD138-) or preplasma memory B cells (B220- CD79b+ CD138-; for review see McHeyzer-Williams and McHeyzer-Williams, 2005).
###end p 26
###begin p 27
###xml 264 291 264 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Shapiro-Shelef et al., 2003</xref>
###xml 293 311 293 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Klein et al., 2006</xref>
###xml 402 429 402 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Shapiro-Shelef et al., 2003</xref>
###xml 599 617 599 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Klein et al., 2006</xref>
Little is known about the transcriptional programs that regulate B cell differentiation into memory cells, including whether there is any role for XBP1 or the UPR in this process. Neither Blimp1 nor IRF4 are required for the development of post-GC memory B cells (Shapiro-Shelef et al., 2003; Klein et al., 2006). Blimp1-deficient B cells, however, fail to differentiate into preplasma memory B cells (Shapiro-Shelef et al., 2003). Furthermore, IRF4-deficient post-GC B cells can expand upon reencounter with cognate antigen (a memory cell-driven response), but they fail to differentiate into PCs (Klein et al., 2006). Thus, neither of these transcription factors appears to be crucial for development of the memory B cell population de novo.
###end p 27
###begin p 28
###xml 85 89 85 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 165 192 165 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Shapiro-Shelef et al., 2003</xref>
###xml 276 280 276 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1011 1014 1002 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 1037 1038 1028 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1041 1043 1032 1034 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 1130 1134 1121 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1143 1146 1134 1137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1153 1161 1144 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">Mice</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
We have already demonstrated that secondary Ig responses are markedly blunted in XBP1CD19 mice (Fig. S2). Using a well established protocol to study memory B cells (Shapiro-Shelef et al., 2003), we next sought to answer whether the defect in secondary memory responses in XBP1CD19 mice is solely attributable to impaired antibody secretion by PCs or whether there may also be independent deficiencies in memory B cell populations themselves. Mice were immunized with 400 microg NP-KLH in Ribi adjuvant and splenocytes were isolated at day 5 or 14. Cells were stained with antibodies specific for CD4, CD8, F4/80 (a macrophage marker), GR1 (a granulocyte and monocyte marker), B220 (CD45R), CD138, IgD, GL7, CD38, and Ig lambda light chain. In addition, cells were stained with propidium iodide (PI) to determine viability and allophycocyanin (APC)-conjugated NP to identify antigen-specific B cells. Viable post-GC NP-specific B cells were identified as those cells that excluded PI, were [CD4, CD8, F4/80, GR1]neg, and demonstrated a NP+IgDlo phenotype. The expansion of these cells after immunization was comparable between XBP1CD19 and XBP1+/+ mice (Fig. 4 A).
###end p 28
###begin p 29
###xml 52 56 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Memory B cells are present in normal numbers in XBP1<sup>CD19</sup> mice.</bold>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 257 262 257 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 267 270 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 276 279 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 300 305 300 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 310 315 310 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cre/+</sup>
###xml 321 325 321 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 424 425 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 462 464 460 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 593 596 591 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 626 630 624 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 667 668 663 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 750 752 746 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 814 817 810 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 837 841 833 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 939 940 933 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1010 1011 1004 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1018 1019 1012 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1024 1026 1018 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 1036 1037 1030 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1086 1089 1080 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1114 1118 1108 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1155 1156 1147 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1181 1182 1173 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1250 1253 1242 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 1257 1259 1249 1251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 1262 1263 1254 1255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1269 1270 1261 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1545 1546 1535 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1571 1572 1561 1562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
###xml 1135 1139 <span type="species:ncbi:10090">mice</span>
###xml 1313 1317 <span type="species:ncbi:10090">mice</span>
Memory B cells are present in normal numbers in XBP1CD19 mice. (A, left) Representative expression of IgD and NP on [PI, CD4, CD8, F4/80, GR1]neg splenocytes of day-14 mice immunized with Ribi (adjuvant) only (left) or NP-KLH in Ribi (right). Shown are XBP1fl/fl CD19+/+ (XBP1+/+) mice (top) and XBP1fl/fl CD19cre/+ (XBP1CD19) littermates (bottom). The inset represents the percentage of cells within profile (mean +/- SEM; n = 3). (A, right) Total number of IgDlo NP-specific B cells from day 0 (naive BALB/c), adjuvant only (day 14 Ribi only), day 5, and day 14 NP-KLH in Ribi immunized XBP1+/+ mice (white columns) and XBP1CD19 (black columns) mice (mean +/- SEM; n = 3). (B, left) Representative expression of B220 and CD138 at the surface of IgDlo NP-specific B cells at days 5 (left) and 14 (right) from XBP1+/+ mice (top) and XBP1CD19 littermates (bottom). The inset represents the percentage of cells within profile (mean +/- SEM; n = 3). (B, right) Total number of NP-specific B cells compartment B220+, CD79b+ B220lo, or CD138+ at day 5 (top) or day 14 (bottom) immunized XBP1+/+ (white columns) and XBP1CD19 (black columns) mice (mean +/- SEM; n = 3; unpaired Student's t test; P > 0.05 for all data points). (C) [PI, CD4, CD8, F4/80, GR1]neg IgDlo NP+ CD138+ splenocytes of day-5 and day-14 immunized mice were sorted directly ex vivo into NP-specific Ig (IgM or IgG) revealing ELISPOT assays. Positives were scored manually under a dissection microscope. Each assay was done in triplicate from three separate animals (mean +/- SEM; n = 3; unpaired Student's t test; *, P </= 0.05).
###end p 29
###begin p 30
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 131 133 131 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 139 140 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 180 183 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 189 190 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 218 226 218 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 354 358 354 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 367 370 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 623 627 623 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 755 758 755 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 762 764 762 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 769 771 769 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 795 798 795 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 802 804 802 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 809 811 809 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 875 879 875 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 888 891 888 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1064 1067 1059 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 1073 1074 1068 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1204 1208 1199 1203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1241 1249 1236 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1389 1393 1384 1388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 1437 1440 1432 1435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 1446 1447 1441 1442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
###xml 1209 1213 <span type="species:ncbi:10090">mice</span>
These NP-specific B cells were further assayed for expression of B220 and CD138 to identify B220+ CD138- post-GC memory cells, B220lo CD79b+ CD138- preplasma memory cells, and B220int CD138+ cells with a PC phenotype (Fig. 4 B). At day 5 after immunization, there were no differences in the relative or absolute numbers of the subpopulations between XBP1CD19 and XBP1+/+ mice. At day 14, there were some differences in the relative numbers of these cells, but the absolute numbers were not significantly different because the number of splenocytes and absolute number of NP-specific cells were up to twofold greater in XBP1CD19 mice. There were no differences in the total number of antigen-specific GC versus post-GC events at day 14 as measured by CD138neg GL7hi CD38lo GC B cells versus CD138neg GL7lo CD38hi post-GC B cells (). There were also no differences between XBP1CD19 and XBP1+/+ mice when assayed for the repertoire of lambda light chain expression by antigen-specific B cells (Fig. S4 B). ELISPOT was used to measure the ability of FACS-purified B220int CD138+ cells to secrete IgM and IgG. At days 5 and 14, the number of NP-specific IgG-secreting B cells was significantly reduced in XBP1CD19 mice as compared with controls (Fig. 4 C). Similar results were obtained for NP-specific IgM-secreting cells at day 5 but not at day 14. These assays reinforce the notion that XBP1CD19 B cells are able to differentiate into B220int CD138+ cells but lack the normal capacity for Ig secretion.
###end p 30
###begin p 31
###xml 10 14 10 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 255 282 255 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Shapiro-Shelef et al., 2003</xref>
###xml 506 510 506 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
Thus, XBP1CD19 B cells are capable of differentiating normally into post-GC or preplasma memory B cell populations. These observations again place XBP1-mediated events downstream of Blimp1, which is crucial for the development of preplasma memory B cell (Shapiro-Shelef et al., 2003). These data also show for the first time that the XBP1-driven branch of the UPR is unnecessary for the development of memory B cells themselves. Thus, the defects in Ig production during secondary antigen challenge in XBP1CD19 mice are solely the result of a failure of formation of antibody-secreting PCs and not of B cell memory itself.
###end p 31
###begin title 32
Summary
###end title 32
###begin p 33
###xml 48 52 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 530 533 530 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 539 540 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 556 560 556 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 881 885 881 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
###xml 932 937 <span type="species:ncbi:10090">mouse</span>
Collectively, this analysis of B cells from XBP1CD19 cKO mice expands our understanding of the crucial role of XBP1 in terminal B cell development as it pertains to PC development, autoantibody-mediated autoimmune disease, and memory cell development. Deletion of XBP1 leads to failed up-regulation of the UPR in developing PCs with subsequent deficiencies in antibody responses to antigen. Interestingly, the experiments presented here identify and characterize a previously unrecognized population of antibody hyposecreting B220int CD138+ B cells in XBP1CD19 mice, demonstrating that XBP1-mediated UPR events occur after the developmental stage at which CD138 is expressed. Importantly, we establish that memory B cell populations are unaffected by XBP1 deficiency such that XBP1-related activity can be situated independent of the memory B cell lineage commitment. Finally, XBP1CD19 mice are protected from autoantibody-mediated mouse lupus. This has therapeutic implications from a clinical perspective in that inhibition of XBP1 or the UPR in general potentially represents a therapeutic target in the treatment of SLE.
###end p 33
###begin title 34
MATERIALS AND METHODS
###end title 34
###begin title 35

###end title 35
###begin title 36
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and immunization.
###end title 36
###begin p 37
###xml 20 24 20 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox</sup>
###xml 130 147 130 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Hetz et al., 2008</xref>
###xml 149 167 149 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Kaser et al., 2008</xref>
###xml 169 185 169 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Lee et al., 2008</xref>
###xml 333 342 333 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 365 370 365 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cre/+</sup>
###xml 476 496 476 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Rickert et al., 1997</xref>
###xml 539 543 539 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 561 564 561 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
The creation of XBP1flox mice harboring loxP sites in the first and second intron of the XBP1 gene has been described previously (Hetz et al., 2008; Kaser et al., 2008; Lee et al., 2008). These mice were backcrossed 10 generations with BALB/c mice, which was the background strain for all experiments described in these studies. XBP1flox/flox mice were bred to CD19cre/+ BALB/c mice that express cre recombinase under the control of the CD19 promoter (The Jackson Laboratory; Rickert et al., 1997). Two generations of breeding yielded XBP1CD19 cKO mice and XBP1+/+ control mice. All mice were born in Mendelian ratios and developed normally. Wild-type BALB/c mice were purchased from Taconic. Experimental protocols were approved by the Standing Committee on Animals at the Harvard Medical School and were designed with institutional and National Institutes of Health guidelines for the humane use of animals.
###end p 37
###begin p 38
###xml 68 72 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 81 84 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 763 789 747 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Baldridge and Crane [1999]</xref>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
To measure serum antibody responses to immunization, 6-8-wk-old XBP1CD19 and XBP1+/+ mice were injected i.p. with 100 microg NP-KLH (Biosearch Technologies) emulsified in alum (Thermo Fisher Scientific) or 25 microg NP-ficoll (Biosearch Technologies). Blood was collected from mice via retroorbital bleed at the time of immunization and weekly for 2 wk. To measure secondary serum antibody responses, some mice that had received NP-KLH were reimmunized with 100 microg NP-KLH in alum 8 wk after primary immunization, and additional blood samples were obtained at the time of reimmunization and weekly for 2 wk. For NP-specific B cell studies, 8-14-wk-old mice were immunized subcutaneously with 400 microg NP-KLH in Ribi adjuvant (laboratory formulation based on Baldridge and Crane [1999]).
###end p 38
###begin title 39
B cell isolation and culture.
###end title 39
###begin p 40
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 181 202 181 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Iwakoshi et al., 2003</xref>
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 479 480 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 512 513 512 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 535 539 535 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 548 551 548 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 576 577 576 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
Single cell suspensions of splenocytes were prepared from 6-8-wk-old mice, and erythrocytes were removed by osmotic lysis with NH4Cl buffer (Sigma-Aldrich) as previously described (Iwakoshi et al., 2003). Splenic B cells were purified using B220+ magnetic bead selection (Miltenyi Biotech) and confirmed to have >90% purity by flow cytometry for cell surface CD19 expression. For some B cell preparations, Southern blotting was used to determine efficacy of XBP1 deletion in B220+ lymphocytes. The remaining B220+ splenocytes from XBP1CD19 and XBP1+/+ mice were cultured at 106 cells/ml for 0-3 d in the presence or absence of 10 microg/ml LPS (Sigma-Aldrich) in complete media containing RPMI 1640 supplemented with 10% FBS (Hyclone Laboratories), 2 mM glutamine, 50 U/ml penicillin, 50 microg/ml streptomycin, 100 mM Hepes, nonessential amino acids, 1 mM sodium pyruvate, and 50 microM beta-mercaptoethanol. Cells were harvested on days 0-3 of culture for RNA extraction and quantitative PCR analysis. In addition, on day 3 of culture, supernatants were tested by enzyme-linked immunosorption assay ELISA to quantify IgM production, cells were harvested for viability assay by annexin V and 7-AAD staining, and cell counts by exclusion of trypan blue.
###end p 40
###begin title 41
Flow cytometry and cell sorting.
###end title 41
###begin p 42
###xml 216 237 216 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Iwakoshi et al., 2007</xref>
###xml 619 636 609 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Hetz et al., 2008</xref>
###xml 675 678 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int</sup>
###xml 684 685 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 715 719 705 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 728 731 718 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
Splenocytes were prepared as described in the previous section. Non-NP-specific flow cytometry and FACS were performed using antibodies specific for mouse IgM, IgD, B220, CD19, or CD138 (BD) as previously described (Iwakoshi et al., 2007). To measure cell viability, cells were stained with PE-conjugated annexin V and 7-AAD according to manufacturer instructions (BD). Viable cells exclude both stains. To measure the cellular content of ER and Golgi organelles, cells were stained with Brefeldin A-BODIPY (Invitrogen) at 0.2 microg/ml at 37degreesC for 40 min before flow cytometric analysis as previously described (Hetz et al., 2008). Cytospin samples of FACS-sorted B220int CD138+ cells were prepared from XBP1CD19 and XBP1+/+ mice and stained with modified Wright-Giemsa stain according to the manufacturer's instructions (Sigma-Aldrich).
###end p 42
###begin p 43
###xml 156 186 156 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">McHeyzer-Williams et al., 2000</xref>
###xml 247 248 247 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
For NP-specific B cell studies, spleens were harvested at day 5 or 14 after immunization and single cell suspensions were prepared as previously described (McHeyzer-Williams et al., 2000). Cell suspensions were labeled for flow cytometry at 2 x 108 cells/ml on ice for 45 min with the following fluorophore-labeled mAbs or Ag: FITC-11.26 (anti-IgD; McHeyzer-Williams laboratory), FITC-GL7 (BD), PE-281.2 (anti-CD138/syndecan-1; BD), PE-90 (anti-CD38; BD), Cy5PE-H129.19 (anti-CD4; BD), Cy5PE-53-6.7 (anti-CD8; BioLegend), Cy5PE-F4/80 (eBioscience), Cy5PE-RB6-8C5 (anti-Ly6G/GR1), Cy7PE-6B2 (antiCD45R/B220), APC-NP (4-hydroxy-5-iodo-3-nitrophenyl; McHeyzer-Williams laboratory), and biotin-HM79b (anti-CD79b/Igbeta; McHeyzer-Williams laboratory). Streptavidin-Cy7APC (BD) was used as a second-step revealing reagent. Cells were washed and resuspended in 2 microg/ml PI for dead cell exclusion in PBS with 5% FCS for analysis. Samples were analyzed using a FACS Vantage SE (BD) and data analyzed using Flow Jo software (Tree Star, Inc.). Profiles are presented as 5% probability contours with outliers.
###end p 43
###begin title 44
ELISA and ELISPOT assays.
###end title 44
###begin p 45
###xml 140 144 140 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 187 207 187 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Reimold et al., 2001</xref>
###xml 590 593 580 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 721 741 711 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Reimold et al., 2001</xref>
###xml 835 853 825 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Kowal et al., 2004</xref>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
ELISA was used to quantify IgM levels in cell culture supernatants and levels of IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA in the serum of XBP1CD19 and XBP1+/+ mice as previously described (Reimold et al., 2001). To measure the relative amounts of NP-specific serum antibodies in mice immunized with NP-KLH or NP-ficoll, plates were coated with 25 microg/ml NP(25)-BSA (Biosearch Technology) overnight at 4degreesC. To standardize and quantify relative amounts of NP-specific IgG responses, all experimental samples were compared with a standardized dilution of pooled serum obtained from XBP1+/+ mice immunized with NP-KLH or NP-ficoll and bled on day 14. NP-specific ELISA was otherwise performed as previously described (Reimold et al., 2001). Serum anti-peptide and anti-dsDNA antibodies were tested by ELISA as previously described (Kowal et al., 2004).
###end p 45
###begin p 46
###xml 79 109 79 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">McHeyzer-Williams et al., 1993</xref>
###xml 111 141 111 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">McHeyzer-Williams et al., 2000</xref>
###xml 363 366 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 370 372 360 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 375 376 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 382 383 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 472 473 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 520 531 <span type="species:ncbi:3704">horseradish</span>
###xml 543 547 <span type="species:ncbi:9925">goat</span>
###xml 553 558 <span type="species:ncbi:10090">mouse</span>
###xml 690 696 <span type="species:ncbi:9606">person</span>
ELISPOT for detection of NP-specific Ig was performed as described previously (McHeyzer-Williams et al., 1993; McHeyzer-Williams et al., 2000). 96-well multiscreen membrane filtration plates (Millipore) were coated with 25 microg/ml NP-BSA overnight at 4degreesC. The wells were washed and incubated with RPMI 1640 and 5% FCS, and 25-50 [PI, CD4, CD8, F4/80, GR1]neg IgDlo NP+ CD138+ cells were sorted directly into each well and incubated for >18 h at 37degreesC in 5% CO2. The wells were washed before the addition of horseradish peroxidase goat anti-mouse IgM or IgG (SouthernBiotech) for 4 h and developed using 3-amino-9-ethylcarbazole (Sigma-Aldrich). Wells were manually scored by a person blinded to the test conditions using a dissection microscope. Each assay was done in triplicate wells from three separate animals.
###end p 46
###begin title 47
Quantitative PCR.
###end title 47
###begin p 48
###xml 365 386 365 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Iwakoshi et al., 2007</xref>
Total RNA was isolated from cells using TRIzol reagent (Invitrogen), and complementary DNA (cDNA) was synthesized from RNA using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems). Quantitative real-time PCR reactions using SYBR green fluorescent reagent were run in an Mx3005P system (Agilent Technologies) and analyzed as previously described (Iwakoshi et al., 2007). Primer sequences are listed in .
###end p 48
###begin title 49
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse lupus.
###end title 49
###begin p 50
###xml 43 61 43 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Kowal et al., 2004</xref>
###xml 79 83 79 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 407 425 399 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Kowal et al., 2004</xref>
###xml 563 579 555 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 852 879 844 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Putterman and Diamond, 1998</xref>
###xml 881 899 873 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Kowal et al., 2004</xref>
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 161 164 <span type="species:ncbi:31658">CFA</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 563 579 <span type="species:ncbi:562">Escherichia coli</span>
###xml 623 627 <span type="species:ncbi:10090">Mice</span>
###xml 719 724 <span type="species:ncbi:10090">mouse</span>
Using an established model of mouse lupus (Kowal et al., 2004), 6-8-wk-old XBP1CD19 and XBP1+/+ mice were immunized i.p. with 100 microg MAP-DWEYS emulsified in CFA (Sigma-Aldrich). Booster immunizations with 100 microg MAP-DWEYS in IFA (Sigma-Aldrich) were given on days 14 and 28. Serum was obtained from these mice on day 35 and tested for anti-peptide and anti-dsDNA antibodies as previously described (Kowal et al., 2004). There were five mice per group. To disrupt the blood brain barrier in the hippocampus, mice were given i.p. injections of 3 mg/kg LPS (Escherichia coli, 055:B5; Sigma-Aldrich) on days 52 and 54. Mice were then killed 4-7 d after LPS treatment to analyze tissues for histological evidence of mouse SLE. After cardiac perfusion, brains and kidneys were isolated and tissues were immunostained for IgG as previously described (Putterman and Diamond, 1998; Kowal et al., 2004).
###end p 50
###begin title 51
Online supplemental material.
###end title 51
###begin p 52
###xml 140 144 140 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 208 212 208 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 343 347 343 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</sup>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
Table S1 lists primer sequences used for quantitative real-time PCR. Fig. S1 shows XBP1 deletion and basal immunoglobulin production in XBP1CD19 mice. Fig. S2 shows immunoglobulin production in immunized XBP1CD19 mice. Fig. S3 shows in vitro analysis of XBP1-deficient B cells. Fig. S4 shows additional characterization of memory cells in XBP1CD19 mice. Online supplemental material is available at .
###end p 52
###begin title 53
Supplementary Material
###end title 53
###begin title 54
[Supplemental Material]
###end title 54
###begin p 55
We would like to acknowledge Dorothy Zhang and RoseAnn Berlin for their expertise in processing the histological samples, Landy Kangaloo for laboratory assistance, and Marisol Avellaneda for assistance with manuscript submission.
###end p 55
###begin p 56
This study was supported by National Institutes of Health grant AI32412 (L.H. Glimcher), The Ellison Foundation (L.H. Glimcher), National Institutes of Health grant T32 AR007530 (D.J. Todd), American College of Rheumatology Fellowship Training Award (D.J. Todd), the American Heart Association Investigator award (A.-H. Lee) and National Institutes of Health grant AI047231 (M.G. McHeyzer-Williams).
###end p 56
###begin p 57
The authors have no conflicting financial interests.
###end p 57
###begin article-title 58
Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo.
###end article-title 58
###begin article-title 59
Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines.
###end article-title 59
###begin article-title 60
PERK mediates cell-cycle exit during the mammalian unfolded protein response.
###end article-title 60
###begin article-title 61
Regulatory mechanisms that determine the development and function of plasma cells.
###end article-title 61
###begin article-title 62
IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA.
###end article-title 62
###begin article-title 63
A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus.
###end article-title 63
###begin article-title 64
B cell development pathways.
###end article-title 64
###begin article-title 65
Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis.
###end article-title 65
###begin article-title 66
XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells.
###end article-title 66
###begin article-title 67
Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1.
###end article-title 67
###begin article-title 68
The transcription factor XBP-1 is essential for the development and survival of dendritic cells.
###end article-title 68
###begin article-title 69
Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.
###end article-title 69
###begin article-title 70
###xml 77 82 <span type="species:ncbi:9606">human</span>
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease.
###end article-title 70
###begin article-title 71
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.
###end article-title 71
###begin article-title 72
Cognition and immunity; antibody impairs memory.
###end article-title 72
###begin article-title 73
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.
###end article-title 73
###begin article-title 74
Functional and molecular characterization of single, (4-hydroxy-3-nitrophenyl)acetyl (NP)-specific, IgG1+ B cells from antibody-secreting and memory B cell pathways in the C57BL/6 immune response to NP.
###end article-title 74
###begin article-title 75
IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response.
###end article-title 75
###begin article-title 76
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells.
###end article-title 76
###begin article-title 77
XBP-1 is required for biogenesis of cellular secretory machinery of exocrine glands.
###end article-title 77
###begin article-title 78
Regulation of hepatic lipogenesis by the transcription factor XBP1.
###end article-title 78
###begin article-title 79
Expression of syndecan-1 inhibits cell invasion into type I collagen.
###end article-title 79
###begin article-title 80
Antigen-specific memory B cell development.
###end article-title 80
###begin article-title 81
Antigen-driven B cell differentiation in vivo.
###end article-title 81
###begin article-title 82
Antigen-specific B cell memory: expression and replenishment of a novel b220(-) memory b cell compartment.
###end article-title 82
###begin article-title 83
###xml 71 75 <span type="species:ncbi:10090">mice</span>
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.
###end article-title 83
###begin article-title 84
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.
###end article-title 84
###begin article-title 85
Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition.
###end article-title 85
###begin article-title 86
Plasma cell differentiation requires the transcription factor XBP-1.
###end article-title 86
###begin article-title 87
###xml 51 55 <span type="species:ncbi:10090">mice</span>
B lymphocyte-specific, Cre-mediated mutagenesis in mice.
###end article-title 87
###begin article-title 88
###xml 33 38 <span type="species:ncbi:9606">human</span>
Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen.
###end article-title 88
###begin article-title 89
Syndecan-1 in B lymphoid malignancies.
###end article-title 89
###begin article-title 90
Syndecan-1: a dynamic regulator of the myeloma microenvironment.
###end article-title 90
###begin article-title 91
B lymphocytes express and lose syndecan at specific stages of differentiation.
###end article-title 91
###begin article-title 92
XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation.
###end article-title 92
###begin article-title 93
Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells.
###end article-title 93
###begin article-title 94
###xml 127 132 <span type="species:ncbi:9606">human</span>
Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells.
###end article-title 94
###begin article-title 95
The endoplasmic reticulum stress response in immunity and autoimmunity.
###end article-title 95
###begin article-title 96
XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.
###end article-title 96
###begin article-title 97
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
###xml 75 85 <span type="species:ncbi:10141">guinea pig</span>
Structure and domain organization of the CD19 antigen of human, mouse, and guinea pig B lymphocytes. Conservation of the extensive cytoplasmic domain.
###end article-title 97
###begin article-title 98
CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum.
###end article-title 98
###begin p 99
###xml 0 19 0 19 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="100">Abbreviations used:</title>
###xml 19 24 19 24 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7-AAD</term>
###xml 24 45 24 45 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="101">7-amino-actinomycin D</p>
###xml 24 45 24 45 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="101">7-amino-actinomycin D</p></def>
###xml 19 45 19 45 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>7-AAD</term><def><p textid="101">7-amino-actinomycin D</p></def></def-item>
###xml 45 48 45 48 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</term>
###xml 48 63 48 63 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="102">allophycocyanin</p>
###xml 48 63 48 63 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="102">allophycocyanin</p></def>
###xml 45 63 45 63 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>APC</term><def><p textid="102">allophycocyanin</p></def></def-item>
###xml 63 66 63 66 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BiP</term>
###xml 66 96 66 96 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="103">Ig heavy chain binding protein</p>
###xml 66 96 66 96 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="103">Ig heavy chain binding protein</p></def>
###xml 63 96 63 96 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>BiP</term><def><p textid="103">Ig heavy chain binding protein</p></def></def-item>
###xml 96 102 96 102 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Blimp1</term>
###xml 102 143 102 143 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="104">B lymphocyte-induced maturation protein 1</p>
###xml 102 143 102 143 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="104">B lymphocyte-induced maturation protein 1</p></def>
###xml 96 143 96 143 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>Blimp1</term><def><p textid="104">B lymphocyte-induced maturation protein 1</p></def></def-item>
###xml 143 149 143 149 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BODIPY</term>
###xml 149 169 149 169 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="105">boron-dipyrromethane</p>
###xml 149 169 149 169 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="105">boron-dipyrromethane</p></def>
###xml 143 169 143 169 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>BODIPY</term><def><p textid="105">boron-dipyrromethane</p></def></def-item>
###xml 169 173 169 173 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cDNA</term>
###xml 173 190 173 190 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="106">complementary DNA</p>
###xml 173 190 173 190 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="106">complementary DNA</p></def>
###xml 169 190 169 190 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>cDNA</term><def><p textid="106">complementary DNA</p></def></def-item>
###xml 190 193 190 193 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cKO</term>
###xml 193 207 193 207 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="107">conditional KO</p>
###xml 193 207 193 207 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="107">conditional KO</p></def>
###xml 190 207 190 207 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>cKO</term><def><p textid="107">conditional KO</p></def></def-item>
###xml 207 212 207 212 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dsDNA</term>
###xml 212 231 212 231 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="108">double-stranded DNA</p>
###xml 212 231 212 231 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="108">double-stranded DNA</p></def>
###xml 207 231 207 231 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>dsDNA</term><def><p textid="108">double-stranded DNA</p></def></def-item>
###xml 231 236 231 236 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERdj4</term>
###xml 236 255 236 255 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="109">ER-localized Dnajb9</p>
###xml 236 255 236 255 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="109">ER-localized Dnajb9</p></def>
###xml 231 255 231 255 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>ERdj4</term><def><p textid="109">ER-localized Dnajb9</p></def></def-item>
###xml 255 257 255 257 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</term>
###xml 257 272 257 272 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="110">germinal center</p>
###xml 257 272 257 272 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="110">germinal center</p></def>
###xml 255 272 255 272 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>GC</term><def><p textid="110">germinal center</p></def></def-item>
###xml 272 275 272 275 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IHC</term>
###xml 275 295 275 295 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="111">immunohistochemistry</p>
###xml 275 295 275 295 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="111">immunohistochemistry</p></def>
###xml 272 295 272 295 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>IHC</term><def><p textid="111">immunohistochemistry</p></def></def-item>
###xml 295 299 295 299 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRE1</term>
###xml 299 353 299 353 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="112">inositol-requiring transmembrane kinase/endonuclease 1</p>
###xml 299 353 299 353 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="112">inositol-requiring transmembrane kinase/endonuclease 1</p></def>
###xml 295 353 295 353 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>IRE1</term><def><p textid="112">inositol-requiring transmembrane kinase/endonuclease 1</p></def></def-item>
###xml 353 357 353 357 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF4</term>
###xml 357 380 357 380 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="113">IFN regulatory factor 4</p>
###xml 357 380 357 380 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="113">IFN regulatory factor 4</p></def>
###xml 353 380 353 380 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>IRF4</term><def><p textid="113">IFN regulatory factor 4</p></def></def-item>
###xml 380 384 380 384 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRNA</term>
###xml 384 397 384 397 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="114">messenger RNA</p>
###xml 384 397 384 397 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="114">messenger RNA</p></def>
###xml 380 397 380 397 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>mRNA</term><def><p textid="114">messenger RNA</p></def></def-item>
###xml 397 399 397 399 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NP</term>
###xml 399 410 399 410 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="115">nitrophenol</p>
###xml 399 410 399 410 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="115">nitrophenol</p></def>
###xml 397 410 397 410 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>NP</term><def><p textid="115">nitrophenol</p></def></def-item>
###xml 410 414 410 414 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax5</term>
###xml 414 431 414 431 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="116">paired box gene 5</p>
###xml 414 431 414 431 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="116">paired box gene 5</p></def>
###xml 410 431 410 431 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>Pax5</term><def><p textid="116">paired box gene 5</p></def></def-item>
###xml 431 433 431 433 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PC</term>
###xml 433 444 433 444 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="117">plasma cell</p>
###xml 433 444 433 444 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="117">plasma cell</p></def>
###xml 431 444 431 444 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>PC</term><def><p textid="117">plasma cell</p></def></def-item>
###xml 444 447 444 447 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDI</term>
###xml 447 474 447 474 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="118">protein disulfide isomerase</p>
###xml 447 474 447 474 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="118">protein disulfide isomerase</p></def>
###xml 444 474 444 474 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>PDI</term><def><p textid="118">protein disulfide isomerase</p></def></def-item>
###xml 474 476 474 476 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PI</term>
###xml 476 492 476 492 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="119">propidium iodide</p>
###xml 476 492 476 492 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="119">propidium iodide</p></def>
###xml 474 492 474 492 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>PI</term><def><p textid="119">propidium iodide</p></def></def-item>
###xml 492 495 492 495 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLE</term>
###xml 495 523 495 523 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="120">systemic lupus erythematosus</p>
###xml 495 523 495 523 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="120">systemic lupus erythematosus</p></def>
###xml 492 523 492 523 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>SLE</term><def><p textid="120">systemic lupus erythematosus</p></def></def-item>
###xml 523 526 523 526 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UPR</term>
###xml 526 551 526 551 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="121">unfolded protein response</p>
###xml 526 551 526 551 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="121">unfolded protein response</p></def>
###xml 523 551 523 551 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>UPR</term><def><p textid="121">unfolded protein response</p></def></def-item>
###xml 551 555 551 555 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XBP1</term>
###xml 555 578 555 578 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="122">X box binding protein 1</p>
###xml 555 578 555 578 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="122">X box binding protein 1</p></def>
###xml 551 578 551 578 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>XBP1</term><def><p textid="122">X box binding protein 1</p></def></def-item>
###xml 0 578 0 578 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="100">Abbreviations used:</title><def-item><term>7-AAD</term><def><p textid="101">7-amino-actinomycin D</p></def></def-item><def-item><term>APC</term><def><p textid="102">allophycocyanin</p></def></def-item><def-item><term>BiP</term><def><p textid="103">Ig heavy chain binding protein</p></def></def-item><def-item><term>Blimp1</term><def><p textid="104">B lymphocyte-induced maturation protein 1</p></def></def-item><def-item><term>BODIPY</term><def><p textid="105">boron-dipyrromethane</p></def></def-item><def-item><term>cDNA</term><def><p textid="106">complementary DNA</p></def></def-item><def-item><term>cKO</term><def><p textid="107">conditional KO</p></def></def-item><def-item><term>dsDNA</term><def><p textid="108">double-stranded DNA</p></def></def-item><def-item><term>ERdj4</term><def><p textid="109">ER-localized Dnajb9</p></def></def-item><def-item><term>GC</term><def><p textid="110">germinal center</p></def></def-item><def-item><term>IHC</term><def><p textid="111">immunohistochemistry</p></def></def-item><def-item><term>IRE1</term><def><p textid="112">inositol-requiring transmembrane kinase/endonuclease 1</p></def></def-item><def-item><term>IRF4</term><def><p textid="113">IFN regulatory factor 4</p></def></def-item><def-item><term>mRNA</term><def><p textid="114">messenger RNA</p></def></def-item><def-item><term>NP</term><def><p textid="115">nitrophenol</p></def></def-item><def-item><term>Pax5</term><def><p textid="116">paired box gene 5</p></def></def-item><def-item><term>PC</term><def><p textid="117">plasma cell</p></def></def-item><def-item><term>PDI</term><def><p textid="118">protein disulfide isomerase</p></def></def-item><def-item><term>PI</term><def><p textid="119">propidium iodide</p></def></def-item><def-item><term>SLE</term><def><p textid="120">systemic lupus erythematosus</p></def></def-item><def-item><term>UPR</term><def><p textid="121">unfolded protein response</p></def></def-item><def-item><term>XBP1</term><def><p textid="122">X box binding protein 1</p></def></def-item></def-list>
Abbreviations used:7-AAD7-amino-actinomycin DAPCallophycocyaninBiPIg heavy chain binding proteinBlimp1B lymphocyte-induced maturation protein 1BODIPYboron-dipyrromethanecDNAcomplementary DNAcKOconditional KOdsDNAdouble-stranded DNAERdj4ER-localized Dnajb9GCgerminal centerIHCimmunohistochemistryIRE1inositol-requiring transmembrane kinase/endonuclease 1IRF4IFN regulatory factor 4mRNAmessenger RNANPnitrophenolPax5paired box gene 5PCplasma cellPDIprotein disulfide isomerasePIpropidium iodideSLEsystemic lupus erythematosusUPRunfolded protein responseXBP1X box binding protein 1
###end p 99
###begin title 100
Abbreviations used:
###end title 100
###begin p 101
7-amino-actinomycin D
###end p 101
###begin p 102
allophycocyanin
###end p 102
###begin p 103
Ig heavy chain binding protein
###end p 103
###begin p 104
B lymphocyte-induced maturation protein 1
###end p 104
###begin p 105
boron-dipyrromethane
###end p 105
###begin p 106
complementary DNA
###end p 106
###begin p 107
conditional KO
###end p 107
###begin p 108
double-stranded DNA
###end p 108
###begin p 109
ER-localized Dnajb9
###end p 109
###begin p 110
germinal center
###end p 110
###begin p 111
immunohistochemistry
###end p 111
###begin p 112
inositol-requiring transmembrane kinase/endonuclease 1
###end p 112
###begin p 113
IFN regulatory factor 4
###end p 113
###begin p 114
messenger RNA
###end p 114
###begin p 115
nitrophenol
###end p 115
###begin p 116
paired box gene 5
###end p 116
###begin p 117
plasma cell
###end p 117
###begin p 118
protein disulfide isomerase
###end p 118
###begin p 119
propidium iodide
###end p 119
###begin p 120
systemic lupus erythematosus
###end p 120
###begin p 121
unfolded protein response
###end p 121
###begin p 122
X box binding protein 1
###end p 122

